国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

The Use of Mesenchymal Stem Cells as A Traditional Medicine

Richard Bradley

The interpretation of Conventional Drugs (TMs) such as Ayurveda, and Conventional Chinese Pharmaceutical into clinical hone remains deterred due to need of logical prove by implies of security, quality, standardization, clinical viability, and mode of activity. These impediments can be ascribed to the need of synonymous in vitro models which reflect in vivo highlights. Human mesenchymal stem cells (hMSCs) have risen as a productive cell source for regenerative pharmaceutical and tissue building. In this survey, the creators talk about how hMSCs can be utilized as an in vitro stage to screen herbs depicted in TMs utilizing advanced strategies such as assessment of its potential, security, quality, mode of activity, etc. Integration of conventional information frameworks like Ayurveda and hMSCs as a stage to screen and consider TMs utilizing present day instruments will viably increment the legitimacy of TMs as evidence-based pharmaceutical.